Malignant Lymphomas in Urethan-Treated Swiss Mice
Author Information
Author(s): B. Toth, G. Della Porta, P. Shubik
Primary Institution: The Chicago Medical School
Hypothesis
Does urethan treatment increase the incidence of malignant lymphomas in Swiss mice?
Conclusion
Urethan treatment resulted in a higher incidence of malignant lymphomas in Swiss mice compared to untreated controls.
Supporting Evidence
- 28% of the urethan-treated females developed lymphomas compared to 16% in controls.
- 15% of the urethan-treated males developed lymphomas compared to 4% in controls.
- Most lymphomas in urethan-treated mice occurred before the 50th week of age.
Takeaway
When Swiss mice drank a special chemical called urethan, many of them got sick with a type of cancer called lymphoma, much more than those that didn't drink it.
Methodology
Swiss albino mice were given urethan in drinking water for two periods of 10 days, with a 10-day interval in between, and then observed for the development of lymphomas.
Limitations
The number of skin tumors was too small to be safely interpreted, and the study was limited to a specific strain of mice.
Participant Demographics
Swiss albino mice, 100 males and 100 females, aged 10 weeks at the start of the experiment.
Want to read the original?
Access the complete publication on the publisher's website